ANIK
Anika Therapeutics, Inc.
Key Financials
Net Income
$-10880000
↑ 80.7%
Gross Profit
$63.8M
↓ 16.0%
Revenue
$112.8M
↓ 5.9%
Operating Income
$-11051000
↓ 116.6%
EPS (Diluted)
$-0.76
↑ 80.2%
Total Assets
$190.3M
↓ 6.2%
Shareholders' Equity
$143.5M
↓ 6.8%
Cash & Equivalents
$57.5M
↑ 3.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/23/2026 | View on SEC |
| 4 | 6/23/2026 | View on SEC |
| 4 | 6/23/2026 | View on SEC |
| 4 | 6/23/2026 | View on SEC |
| 4 | 6/23/2026 | View on SEC |
| 8-K | 6/23/2026 | View on SEC |
| DEFA14A | 6/8/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| DEFA14A | 6/1/2026 | View on SEC |
| 4 | 5/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ANIK |
| Company Name | Anika Therapeutics, Inc. |
| CIK | 898437 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (781) 457-9000 |